BROCCO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 650
EU - Europa 640
AS - Asia 124
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.420
Nazione #
US - Stati Uniti d'America 649
IT - Italia 247
IE - Irlanda 177
SE - Svezia 104
CN - Cina 38
SG - Singapore 27
RU - Federazione Russa 21
TR - Turchia 20
FR - Francia 17
UA - Ucraina 17
VN - Vietnam 17
CZ - Repubblica Ceca 14
DE - Germania 14
IN - India 13
GB - Regno Unito 10
BE - Belgio 6
FI - Finlandia 5
PK - Pakistan 5
AU - Australia 3
HK - Hong Kong 2
JP - Giappone 2
PT - Portogallo 2
RO - Romania 2
AR - Argentina 1
AT - Austria 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
NL - Olanda 1
PL - Polonia 1
SC - Seychelles 1
Totale 1.420
Città #
Chandler 180
Dublin 172
Chieti 82
Ashburn 57
Jacksonville 48
Princeton 46
Altamura 23
Boardman 22
Dong Ket 17
Izmir 17
Wilmington 17
Rome 15
Los Angeles 14
Ann Arbor 13
Lanciano 13
L’Aquila 13
Dearborn 12
Singapore 12
Brno 11
New York 11
Beijing 10
Pescara 9
Pune 9
Nanjing 8
Norwalk 8
Houston 7
Washington 7
Brussels 6
Corridonia 6
Falls Church 6
Oklahoma City 6
Seattle 6
Islamabad 5
Milan 5
Woodbridge 5
Cambridge 4
Carini 4
Loma Linda 4
Bari 3
Changsha 3
Jiaxing 3
Nanchang 3
Olomouc 3
Perth 3
Sulmona 3
Ameno 2
Andover 2
Antrodoco 2
Charlotte 2
Edinburgh 2
El Segundo 2
Garden City 2
Grevenbroich 2
Guangzhou 2
Hangzhou 2
Helsinki 2
Lappeenranta 2
London 2
Loreto Aprutino 2
Moscow 2
Oxford 2
Pistoia 2
Redlands 2
San Vito Chietino 2
Shanghai 2
Simi Valley 2
Xi'an 2
Amsterdam 1
Ancona 1
Bologna 1
Boydton 1
Buenos Aires 1
Chiaravalle 1
Civitavecchia 1
East Falmouth 1
Elice 1
Fairfield 1
Frankfurt am Main 1
Hanover 1
Hebei 1
Hefei 1
Indianapolis 1
Lisbon 1
Madrid 1
Montecastrilli 1
Montesilvano Marina 1
Montreal 1
Mumbai 1
Munich 1
Phoenix 1
Pianella 1
Porto 1
Prato 1
Redwood City 1
Rovigo 1
Rozzano 1
San Mateo 1
San Salvo 1
Shenyang 1
Spoltore 1
Totale 1.008
Nome #
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 93
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 78
Exosomes as pleiotropic players in pancreatic cancer 76
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 70
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 68
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 68
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 68
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study 65
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 62
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 59
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 59
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 58
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 49
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 45
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 44
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 42
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy 42
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 40
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 39
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 38
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 37
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 37
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents 35
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 33
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 30
Prognostic value of gender and primary tumor location in metastatic colon cancer 30
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 29
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 26
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 25
Deep polychromatic flow cytometry characterization of circulating endothelial cells in metastatic colorectal cancer patients 23
P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC 22
null 21
Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol 19
Novel strategies exploiting interleukin-12 in cancer immunotherapy 16
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 14
null 14
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 4
From cachexia to obesity: the role of host metabolism in cancer immunotherapy 1
Totale 1.579
Categoria #
all - tutte 7.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 32 2 6 4 12 13 16 2 12 16 35 2
2020/2021124 26 0 18 3 5 21 2 4 5 5 3 32
2021/2022179 2 5 8 52 2 25 12 8 11 3 12 39
2022/2023583 38 70 77 52 38 93 29 76 58 5 22 25
2023/2024446 36 5 28 35 13 135 65 17 11 19 9 73
2024/202530 30 0 0 0 0 0 0 0 0 0 0 0
Totale 1.579